Weighted Average Number of Shares Outstanding, Diluted of MADRIGAL PHARMACEUTICALS, INC. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
MADRIGAL PHARMACEUTICALS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • MADRIGAL PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 22,482,502, a 3.4% increase year-over-year.
  • MADRIGAL PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 21,272,962, a 14% increase from 2023.
  • MADRIGAL PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 18,687,774, a 9% increase from 2022.
  • MADRIGAL PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 17,137,201, a 3.6% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 22,482,502 +736,573 +3.4% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 22,207,017 +804,371 +3.8% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 22,091,314 +2,089,745 +10% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 21,272,962 +1,512,120 +7.7% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
Q3 2024 21,745,929 +3,269,515 +18% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 21,402,646 +3,091,694 +17% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 20,001,569 +1,813,645 +10% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 19,760,842 +2,523,325 +15% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
Q3 2023 18,476,414 +1,373,019 +8% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 18,310,952 +1,207,557 +7.1% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 18,187,924 +1,084,529 +6.3% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 17,237,517 +162,974 +0.95% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 17,103,395 +463,619 +2.8% 01 Jul 2022 30 Sep 2022 10-K 28 Feb 2024 2023 FY
Q2 2022 17,103,395 +532,073 +3.2% 01 Apr 2022 30 Jun 2022 10-K 28 Feb 2024 2023 FY
Q1 2022 17,103,395 +1,262,994 +8% 01 Jan 2022 31 Mar 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 17,074,543 01 Oct 2021 31 Dec 2021 10-K/A 03 Mar 2023 2022 FY
Q3 2021 16,639,776 01 Jul 2021 30 Sep 2021 10-K/A 03 Mar 2023 2022 FY
Q2 2021 16,571,322 01 Apr 2021 30 Jun 2021 10-K/A 03 Mar 2023 2022 FY
Q1 2021 15,840,401 01 Jan 2021 31 Mar 2021 10-K/A 03 Mar 2023 2022 FY
Q1 2012 56,366,992 +14,358,174 +34% 01 Jan 2012 31 Mar 2012 10-Q 03 May 2012 2012 Q1
Q4 2011 47,197,572 01 Oct 2011 31 Dec 2011 10-K 22 Feb 2012 2011 FY
Q3 2011 42,211,858 +1,828,996 +4.5% 01 Jul 2011 30 Sep 2011 10-Q 03 Nov 2011 2011 Q3
Q2 2011 42,166,739 +1,824,068 +4.5% 01 Apr 2011 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q1 2011 42,008,818 01 Jan 2011 31 Mar 2011 10-Q 03 May 2012 2012 Q1
Q3 2010 40,382,862 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011 2011 Q3
Q2 2010 40,342,671 01 Apr 2010 30 Jun 2010 10-Q 04 Aug 2011 2011 Q2

MADRIGAL PHARMACEUTICALS, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 21,272,962 +2,585,188 +14% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
2023 18,687,774 +1,550,573 +9% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
2022 17,137,201 +602,013 +3.6% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 16,535,188 +1,088,550 +7% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 15,446,638 01 Jan 2020 31 Dec 2020 10-K/A 03 Mar 2023 2022 FY
2011 47,197,572 +6,832,357 +17% 01 Jan 2011 31 Dec 2011 10-K 22 Feb 2012 2011 FY
2010 40,365,215 01 Jan 2010 31 Dec 2010 10-K 22 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.